People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Biotechnology, Pharmaceuticals, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adicet Bio, Inc. | — | Biotechnology | Series C | $116.8M | $3.3B | 2015 |
| Hyperion Therapeutics Inc | — | Pharmaceuticals | Series B | $67.9M | $271.7M | 2009 |
| Ocelot Bio, Inc. | — | Pharmaceuticals | Series B | $39.0M | $31.0M | 2023 |
| Abilitech Medical, Inc. | — | Healthtech | Series A | $12.7M | $42.5M | 2018 |
Donald Santel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Donald Santel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 1 | 24 |
| Asish Xavier | 1 | 18 |
| Jack Nielsen | 1 | 13 |
| Jonathan Silverstein | 1 | 10 |
| James Healy | 1 | 8 |
| Erez Chimovits | 1 | 7 |
| James I. Healy | 1 | 7 |
| Michal Silverberg | 1 | 7 |
| Rob Hopfner | 1 | 6 |
| Camille Samuels | 1 | 6 |
| Aaron Fletcher | 1 | 5 |
| Elona Baum | 1 | 5 |
| Jake Nunn | 1 | 5 |
| Bijan Salehizadeh | 1 | 5 |
| Daniel Perez | 1 | 5 |
| Lota S Zoth | 1 | 4 |
| Yair Schindel | 1 | 4 |
| Geoffrey Harris | 1 | 4 |
| Florent Gros | 1 | 4 |
| Jake R. Nunn | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.